Concepedia

Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder

Scott E. Hadland, Sarah M. Bagley, Jonathan Rodean, Michael Silverstein, Sharon Levy, Marc R. Larochelle, Jeffrey H. Samet, Bonnie T. Zima

JAMA Pediatrics · 2018 · 203 citations · 28 references

DOIFull text

Open access

Abstract

Timely receipt of buprenorphine, naltrexone, or methadone was associated with greater retention in care among youths with OUD compared with behavioral treatment only. Strategies to address the underuse of evidence-based medications for youths with OUD are urgently needed.

References

28

Trends in Opioid Prescribing by Race/Ethnicity for Patients Seeking Care in US Emergency Departments

Mark J. Pletcher, Stefan G. Kertesz, Michael A. Kohn et al. · JAMA · 2008 · 826 citations

American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use

Kyle M. Kampman, Margaret Jarvis · Journal of Addiction Medicine · 2015 · 667 citations · Full text

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Evgeny Krupitsky, Edward V. Nunes, Walter Ling et al. · The Lancet · 2011 · 543 citations

, , +14

Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Jon E. Zibbell, Kashif Iqbal, Rajiv Patel et al. · PubMed · 2015 · 515 citations · Full text

, , +21

Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder

Roger A. Rosenblatt, C. Holly A. Andrilla, Mary Catlin et al. · The Annals of Family Medicine · 2015 · 388 citations · Full text